432 related articles for article (PubMed ID: 38486294)
1. Optical nanomaterial-based detection of biomarkers in liquid biopsy.
Kim YJ; Rho WY; Park SM; Jun BH
J Hematol Oncol; 2024 Mar; 17(1):10. PubMed ID: 38486294
[TBL] [Abstract][Full Text] [Related]
2. Recent Advancements in Nanoparticle-Based Optical Biosensors for Circulating Cancer Biomarkers.
Amri C; Shukla AK; Lee JH
Materials (Basel); 2021 Mar; 14(6):. PubMed ID: 33802028
[TBL] [Abstract][Full Text] [Related]
3. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in nanomaterial-based biosensors for the detection of exosomes.
Zhang L; Gu C; Wen J; Liu G; Liu H; Li L
Anal Bioanal Chem; 2021 Jan; 413(1):83-102. PubMed ID: 33164151
[TBL] [Abstract][Full Text] [Related]
5. CTC, ctDNA, and Exosome in Thyroid Cancers: A Review.
Wang W; Zheng Z; Lei J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762070
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
8. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
Liu C; Yang Y; Wu Y
AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
[TBL] [Abstract][Full Text] [Related]
10. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
Marrugo-Ramírez J; Mir M; Samitier J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in nanotechnology-enabled biosensors for detection of exosomes as new cancer liquid biopsy.
Hsu CC; Wu Y
Exp Biol Med (Maywood); 2022 Dec; 247(23):2152-2172. PubMed ID: 35938477
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects.
Kim YJ; Min J
Anal Bioanal Chem; 2024 Apr; 416(9):2065-2078. PubMed ID: 37963993
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis.
Mali SB; Dahivelkar S
Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
[TBL] [Abstract][Full Text] [Related]
15. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
[TBL] [Abstract][Full Text] [Related]
16. Exosome-based liquid biopsies in cancer: opportunities and challenges.
Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
[TBL] [Abstract][Full Text] [Related]
17. DNA Nanomaterial-Based Optical Probes for Exosomal miRNA Detection.
Tang J; Li Q; Yao C; Yang D
Chempluschem; 2023 Jan; 88(1):e202200345. PubMed ID: 36650721
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
19. Using Liquid Biopsy in the Treatment of Patient with OS.
Shulman DS; Crompton BD
Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
